[Remote results of combined treatment of operable stomach cancer]

The rationale of using preoperative radiotherapy as an adjunct in the combination therapy of gastric cancer is discussed. 102 patients mostly with the process in stage III (91) were treated. The analysis made enabled the authors to reveal a significant increase of resectability in a group of patients receiving distant gammatherapy. This index was 72.2% versus generally accepted indices 55--65%. The survival in this group of patients with terms of the follow-up from 5 to 8 years made 32.3% versus 20.8% of only a 5-year survival in a group of patients treated surgically.